The diagnostic accuracy of the immunocytochemical markers in the pre-operative evaluation of follicular thyroid lesions

Journal of Endocrinological Investigation

Volumn 33, Issue 6, 2010, Pages 378-381

  Raggio, E ^a   Camandona, M ^a   Solerio, D ^a   Martino, P ^a   Franchello, A ^a   Orlandi, F ^a   Gasparri, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

CK19; Follicular thyroid lesion; GAL3; HBME 1

Indexed keywords

BIOTIN; CELL SURFACE MESOTHELIAL ANTIGEN; CYTOKERATIN 19; GALECTINE 3; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GALECTIN 3; HBME-1 ANTIGEN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID FOLLICULAR ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY; ADENOCARCINOMA, FOLLICULAR; ADENOMA; BIOSYNTHESIS; CHEMISTRY; DIAGNOSTIC ERROR; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; MIDDLE AGED; PREDICTIVE VALUE; PREOPERATIVE CARE; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; DIAGNOSTIC ERRORS; FEMALE; GALECTIN 3; GENE EXPRESSION; HUMANS; KERATIN-19; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL;

EID: 77955390678     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/6444     Document Type: Article

References (20)

1. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993, 328: 553-9.
2. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004, 351: 1764-71.
3. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effects. Mayo Clinic Proc 1994, 69: 44-9. (Pubitemid 24016915)
4. Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin North Am 1995, 24: 663-710.
5. Cochand-Priollet B, Guillausseau PJ, Chagnon S, et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. Am J Med 1994, 97: 152-7.
6. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration citology. Diagn Cytopathol 2002, 26: 41-4.
7. Lin JD, Hsueh C, Chao TC, et al. Thyroid follicular neoplasms diagnosed by high-resolution ultrasonography with fine-needle aspiration cytology. Acta Cytol 1997, 41: 687-91.
8. Liou MJ, Chan EC; Lin JD, Liu FH, Chao TC. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett 2003, 191: 223-7.
9. Czyz W, Balcerczak E, Jakubiak M, Pasieka Z, Kuzdak K, Mirowski M. HMGI(Y) gene expression as potenyial marker of thyroid follicular carcinoma. Langenbecks Arch Surg 2004, 389: 193-97.
10. van Hoeven KH, Kovatich AJ, Miettinen M. Immunocytochemical evaluation of HBME-1, CA 19-9 and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules. Diagn Cytopathol 1998, 18: 93-7.
11. Prasad ML, Pellegata NS, Huang Y, Nagaraja HN, Chapelle A, Kloos RT. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 2005, 18: 48-57.
12. Henry JF, Denizot A, Porcelli A, et al. Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules. World J Surg 1994, 18: 529-34.
13. Khurana KK, Truong LD, LiVolsi VA, Baloch ZW. Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis of papillary thyroid carcinoma. Arch Pathol Lab Med 2003, 127: 579-83.
14. Bartolazzi A, Gasbarri A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001, 357: 1644-50.
15. Lloyd RV. Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate. Endocr Pathol 2001, 12: 255-7.
16. Xu XC, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995, 147: 815-22.
17. Fernández PL, Merino MJ, Gómez M, et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997, 181: 80-6.
18. Bartolazzi A, Papotti M, Orlandi F. Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules. J Clin Endocrinol Metab 2003, 88: 950-1.
19. Sahoo S, Hoda SA, Rosai J, DeLellis RA. Cytokeratin 19 immunoraectivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol 2001, 116: 696-702.
20. Saggiorato E, De Pompa R, Volante M, et al. Characterization of thyroid "follicular neoplasms" in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 2005, 12: 305-17.